A healthy recovery: The issue facing the pharma industry

Getting the sector back in shape

clock • 4 min read

Imagine you are a business owner and you are presented with an enormous gap in your market that needs filling and there is a dearth of competition.

But what if the products that would fill that gap are not only unprofitable, but become less valuable the more people use them? What would you do?  This is the issue facing the pharmaceutical industry, which the world depends on to provide the bedrock of modern healthcare - antibiotics. Investment in new antibiotics has slowed to the lowest rate in history, and big pharmaceutical companies have largely abandoned the field.  Modern healthcare systems are built on the ability to control infection, and our tools in that fight - antibiotics - were in crisis even before Covid-19 hit.  C...

To continue reading this article...

Join Investment Week for free

  • Unlimited access to real-time news, analysis and opinion from the investment industry, including the Sustainable Hub covering fund news from the ESG space
  • Get ahead of regulatory and technological changes affecting fund management
  • Important and breaking news stories selected by the editors delivered straight to your inbox each day
  • Weekly members-only newsletter with exclusive opinion pieces from leading industry experts
  • Be the first to hear about our extensive events schedule and awards programmes

Join now

 

Already an Investment Week
member?

Login

More on ESG

SDR 'not straightforward' for MPS providers and DFMs
ESG

SDR 'not straightforward' for MPS providers and DFMs

‘Serious amount of additional resource’ needed

Isabel Baxter
clock 30 January 2025 • 4 min read
Schroders becomes first adopter of all four SDR labels
ESG

Schroders becomes first adopter of all four SDR labels

First 'Sustainability Mixed Goals' label

Linus Uhlig
clock 27 January 2025 • 1 min read
Global ESG fund flows reach highest quarterly inflows of 2024 in Q4 boom
ESG

Global ESG fund flows reach highest quarterly inflows of 2024 in Q4 boom

Driven by European strategies

Sorin Dojan
clock 27 January 2025 • 3 min read
Trustpilot